Zenosense, Inc. (ZENO) Stock Analysis

Why this analysis is different

• A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Zenosense, Inc. (ZENO) Financial Services Profile

Zenosense, Inc., formerly a healthcare technology company, now operates as a shell company seeking acquisition opportunities via reverse mergers or asset purchases. Based in New York, the company's current strategy focuses on identifying and securing a new business venture, reflected in its limited operational activity.

What Is the Investment Thesis for ZENO?

Zenosense, Inc. presents a speculative investment opportunity given its status as a shell company actively seeking a business to acquire. The company's market capitalization is approximately $0.00 billion, with a P/E ratio of -0.05 and a beta of -115.63. The absence of a dividend reflects its current operational inactivity. The investment thesis hinges on the successful identification and acquisition of a promising business, which could potentially drive significant value appreciation. However, the high beta suggests extreme volatility. Key risks include the failure to find a suitable acquisition target and the potential dilution of existing shareholders. The timeline for a potential acquisition is uncertain, adding to the speculative nature of the investment.

Based on FMP financials and quantitative analysis

ZENO Key Highlights

Market Cap of $0.00B reflects its status as a shell company with limited operations.

• P/E Ratio of -0.05 indicates the company is not currently profitable.
• Beta of -115.63 suggests extreme volatility and sensitivity to market movements.
• No Dividend is currently paid, aligning with its focus on seeking acquisition opportunities.
• Strategic shift from healthcare technology to identifying acquisition targets.

Who Are ZENO's Competitors?

ZENO is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are ZENO's Key Strengths?

Existing corporate structure

• Flexibility in acquisition strategies
• Potential for rapid value creation

What Are ZENO's Weaknesses?

Lack of current operations

• Dependence on finding a suitable acquisition target
• High level of uncertainty

What Could Drive ZENO Stock Higher?

Identification of a potential acquisition target.

• Announcement of a reverse merger agreement.
• Completion of an asset purchase transaction.

What Are the Key Risks for ZENO?

Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.

• Failure to identify a suitable acquisition target.
• Dilution of existing shareholders through new share issuance.
• Increased competition from other shell companies and SPACs.
• Limited liquidity and trading volume on the OTC market.
• Lack of operational activity and revenue generation.

What Are the Growth Opportunities for ZENO?

• Acquisition of a High-Growth Business: Zenosense's primary growth opportunity lies in acquiring a promising private company with significant growth potential. The target company could be in any sector, but high-growth areas like technology or healthcare are likely candidates. The success of this strategy depends on Zenosense's ability to conduct thorough due diligence and negotiate favorable terms. The timeline for this opportunity is dependent on market conditions and the availability of suitable targets.
• Reverse Merger with a Private Company: A reverse merger would allow a private company to become publicly traded by merging with Zenosense. This strategy offers a faster and potentially less expensive route to the public markets compared to a traditional IPO. The potential market size for reverse mergers is substantial, with numerous private companies seeking public listings. The timeline depends on identifying a suitable merger partner and completing the necessary regulatory approvals.
• Asset Purchase of a Distressed Business: Zenosense could acquire the assets of a distressed company at a discounted price. This strategy could provide a quick and cost-effective way to acquire valuable assets and potentially revive a struggling business. The market for distressed assets fluctuates with economic cycles, but opportunities often arise during periods of economic downturn. The timeline depends on identifying suitable distressed assets and negotiating favorable purchase terms.
• Strategic Partnership with a Private Equity Firm: Zenosense could partner with a private equity firm to identify and acquire a target company. This partnership would provide access to additional capital and expertise, increasing the likelihood of a successful acquisition. The private equity market is large and active, with numerous firms seeking investment opportunities. The timeline depends on establishing a partnership and identifying a suitable target company.
• Capitalizing on Market Volatility: Market volatility can create opportunities for shell companies like Zenosense to acquire undervalued assets or businesses. During periods of market uncertainty, some companies may be willing to sell assets or merge at a lower valuation. Zenosense could capitalize on this volatility by identifying and acquiring these undervalued opportunities. The timeline for this opportunity is dependent on market conditions and the availability of distressed assets.

What Are ZENO's Competitive Advantages?

• Existing corporate structure facilitates acquisitions.
• Flexibility to pursue various acquisition strategies.
• Potential to provide a faster route to public markets for private companies.

What Does ZENO Do?

Zenosense, Inc., incorporated in 2008 and based in New York City, represents a unique entity within the financial services sector. Originally established as Braeden Valley Mines, Inc., the company underwent a name change in November 2013, signaling a shift in its business focus. Previously, Zenosense operated as a healthcare technology company. However, as of the current date, Zenosense, Inc. does not have significant ongoing operations. The company's primary objective now revolves around exploring and identifying potential business opportunities. These opportunities are centered on acquiring a business through various means, including a reverse merger, asset purchase, or other similar transactional structures. This strategic direction indicates a pivot towards leveraging its existing corporate structure to facilitate the entry or expansion of another company into the public market. The company's evolution from a healthcare technology focus to a shell corporation highlights its adaptability and willingness to pursue new avenues for value creation.

What Products and Services Does ZENO Offer?

• Currently operates as a shell company.
• Seeks to acquire a business through reverse merger.
• Considers asset purchases as an acquisition strategy.
• Explores business opportunities for value creation.
• Formerly operated as a healthcare technology company.
• Aims to facilitate a private company's entry into the public market.

How Does ZENO Make Money?

• Identifies potential acquisition targets.
• Negotiates terms for reverse mergers or asset purchases.
• Leverages existing corporate structure for acquisitions.

What Industry Does ZENO Operate In?

Zenosense, Inc. operates within the shell company industry, a segment of the financial services sector characterized by entities with minimal operations that seek to acquire or merge with private companies, enabling them to go public without undergoing a traditional IPO. This market is driven by companies seeking faster and less regulated access to public markets. The competitive landscape includes other shell companies and special purpose acquisition companies (SPACs). The success of Zenosense depends on its ability to identify and execute a value-accretive acquisition in a competitive environment.

Who Are ZENO's Key Customers?

• Private companies seeking to go public.
• Investors interested in early-stage growth opportunities.
• Private equity firms seeking partnership opportunities.

Company Profile

Zenosense, Inc. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in New York City, US. The company is led by CEO Zhongjian Hu. ZENO has traded publicly since 2014.

Zenosense, Inc. (ZENO) Valuation Context

Relative to its peer group, ZENO's quantitative score of 44/100 is below the peer average of 63/100.

Return on equity for Zenosense, Inc. stands at 34.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. Its free cash flow yield is -35.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.

Zenosense, Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.

ZENO Financials

ZENO Latest News

No recent news available for ZENO.

ZENO Analyst Consensus

ZENO MoonshotScore

Common Questions About ZENO (Financial Services)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources